Deep Brain Stimulators Market Share, Growth, Size, Research and Forecast 2019-2025

Deep brain stimulators market is expected to grow at a CAGR of 7.2% during the forecast period. Deep brain stimulation is a method to implant electrodes in a certain area of the brain. The electrodes generate electrical impulse which regulates abnormal impulses. A device similar to the pacemaker is implanted under the skin of the upper chest. The wire travels under the skin and connects device to the electrode to the brain. Deep brain stimulators can treat various diseases which include Parkinson's disease, dystonia, epilepsy, essential tremor, obsessive-compulsive disorder and so on. Studies are also undergoing for the potential treatment of cluster headache, dementia, depression, Huntington's disease and others.

Request a free sample of our report on Deep Brain Stimulators Market: https://www.omrglobal.com/request-sample/deep-brain-stimulators-market

Also, it is approved by the US FDA to reduce seizures in difficult-to-treat epilepsy, whose symptoms cannot be controlled by the use of medication. It is minimally invasive and involves creating small holes in the skull to implant the electrodes. By surgery, batteries under the skin in the chest are implanted. Deep brain stimulation does not destroy the brain tissue; however, it reversibly alters the abnormal function of the brain tissue in the region of the stimulating electrode. Patient with moderate disability from Parkinson’s disease can opt for this surgery. Incidences of Parkinson’s disease is increasing considerably across the globe. In 2017, as per the Institute for Health Metrics and Evaluation, incidence of Parkinson’s disease was more than a million as compared to nearly 912,000 in 2013. Around 10 million people are living with Parkinson’s disease in 2019, globally.

A full report of Deep Brain Stimulators Market: https://www.omrglobal.com/industry-reports/deep-brain-stimulators-market

In February 2019, Medtronic PLC launched deep brain stimulation for medically refractory epilepsy. The product was launched after pre-market approval from the US FDA for epilepsy as an adjunctive treatment for reducing the frequency of partial-onset seizures in individuals over 18 years of age. The US FDA approved it, based on the results from the SANTE (Stimulation of the anterior nucleus of the thalamus in epilepsy) trial.

Deep Brain Stimulators Market – Segmentation

By Product

• Single Channel
• Dual Channel

By Applications

• Parkinson’s Disease
• Depression
• Others

By End-Users

• Hospitals and Clinics
• Research Institutes

Deep Brain Stimulators Market - Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

Company Profiles

• Abbott Laboratories (St. Jude Medical)
• Beijing PINS Medical Co. Ltd.
• Boston Scientific Corp.
• Fisher Wallace
• Functional Neuromodulation Ltd.
• Medtronic PLC
• NeuroPace Inc.
• Renishaw PLC
• Enteromedics
• Cyberonics
• Neurosigma

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/deep-brain-stimulators-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.